학술논문
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models
Document Type
Article
Source
In: Medical Oncology . (Medical Oncology, December 2022, 39(12))
Subject
Language
English
ISSN
1559131X
13570560
13570560